Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$5,822,770
+$240,005 QoQ
Shares Held
22,927
+0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.26%
of 13F equity value
Holder Rank
#1,501
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Patten Group, Inc. holds $22,707,053 across 8 Drug Manufacturers - General names. JNJ ranks #1 (25.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
22,927 | $5,822,770 | |
| 2 | AZN |
Astrazeneca PLC
|
29,983 | $5,685,376 | |
| 3 | MRK |
Merck & Co., Inc.
|
26,376 | $3,389,316 | |
| 4 | LLY |
ELI LILLY & Co
|
2,822 | $3,384,791 | |
| 5 | NVS |
Novartis AG
|
16,667 | $2,612,051 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,094 | $1,100,195 | |
| 7 | ABBV |
AbbVie Inc.
|
1,875 | $471,824 | |
| 8 | SNY |
Sanofi
|
5,643 | $240,730 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,822,770 | 22,927 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $5,582,765 | 22,839 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $4,647,683 | 22,458 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $4,149,514 | 22,379 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,418,239 | 22,378 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $3,688,115 | 22,239 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,249,466 | 22,469 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,787,666 | 23,372 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $3,629,883 | 24,835 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $4,002,207 | 25,300 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $3,952,826 | 25,219 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $3,887,364 | 24,959 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $5,097,684 | 30,798 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $4,674,645 | 30,159 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $5,248,094 | 29,709 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $4,879,399 | 29,869 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $5,330,625 | 30,030 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $5,337,104 | 30,114 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $5,135,692 | 30,021 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $4,521,515 | 27,997 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,568,404 | 27,731 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $4,410,989 | 26,839 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $4,171,829 | 26,508 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $3,653,812 | 24,542 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $3,394,386 | 24,137 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $3,186,721 | 24,302 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||